Table 1 Relationship between the expression of HSPB6 in prostate cancer and clinicopathological parameters.

From: 8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer

Characteristics

N

HSPB6-high

HSPB6-low

χ2

P

Age

 ≥70

62

33

29

0.027

0.869

 <70

58

30

28

  

Gleason score

 ≥8

43

15

28

8.339

0.004*

 <8

77

48

29

  

T classification

 T3, T4

73

31

42

7.525

0.006*

 T1, T2

47

32

15

  

Lymph node metastasis

 Present

41

14

27

8.413

0.004*

 Absent

79

49

30

  

Distant metastasis

 Present

52

19

33

9.375

0.002*

 Absent

68

44

24

  
  1. *Means P < 0.05